VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Excretion of catecholamines and DOPA in lipid metabolism disorders

   
Frolova I.A., Oleneva V.A., Paramonova E.G., Volkova I.S., Sirota I.I.
PubMed Id: 595486
Year: 1977  Volume: 23  Issue: 6  Pages: 797-803
Excretion of catecholamines and DOPA was impaired in patients with metabolic-alimentary obesity, with ischemic disease of heart, with atherosclerosis and excessive weight. Distinct decrease in content of adrenaline, noradrenaline and DOPA was observed in patients with obesity; the phenomenon was less pronounced in ischemic disease of heart, mainly in aged patients. Correlation was found between the rate of excretion of catecholamines and DOPA and the extent of hyperlipidemia. Dietetics did not normalize completely the impairments studied. Additional administration of pyridoxine caused a favorable effect.
Download PDF:  
Citation:

Frolova, I. A., Oleneva, V. A., Paramonova, E. G., Volkova, I. S., Sirota, I. I. (1977). Excretion of catecholamines and DOPA in lipid metabolism disorders. Voprosy Meditsinskoi Khimii, 23(6), 797-803.
References
 1984 (vol 30)
 1983 (vol 29)
 1982 (vol 28)
 1981 (vol 27)
 1980 (vol 26)
 1979 (vol 25)
 1978 (vol 24)
 1977 (vol 23)
 1976 (vol 22)
 1975 (vol 21)
 1974 (vol 20)
 1973 (vol 19)
 1972 (vol 18)
 1971 (vol 17)
 1970 (vol 16)
 1969 (vol 15)
 1968 (vol 14)
 1967 (vol 13)
 1966 (vol 12)
 1965 (vol 11)